Skip to main content
HeartCited

Folate (Vitamin B9) के लिए Coronary Artery Disease (CAD)

C साक्ष्य की तुलना करें छोटे अध्ययनों से सीमित साक्ष्य उपलब्ध हैं, लेकिन कुछ सकारात्मक संकेत मौजूद हैं।

CSPPT showed stroke benefit but not MI benefit. HOPE-2 was negative for cardiovascular events despite homocysteine reduction. Research suggests benefit may be limited to populations without folic acid fortification.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dfolate\u0026condition\u003Dcoronary\u002Dartery\u002Ddisease'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

निष्कर्ष

CSPPT showed stroke benefit but not MI benefit. HOPE-2 was negative for cardiovascular events despite homocysteine reduction. Research suggests benefit may be limited to populations without folic acid fortification.

Key Study Findings

cross-sectional n=800
Excessive Daytime Sleepiness is Associated With Malnutrition, Dysphagia, and Vitamin D Deficiency in Older Adults.
Dose: None बनाम: Placebo प्रभाव: OR 1.73 (malnutrition), OR 2.01 (dysphagia), OR 2.0 (vitamin D deficiency) <0.05
Meta-Analysis n=129
Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes: An Umbrella Review and Evidence …
Dose: None बनाम: None Outcome: Mortality प्रभाव: None None

जनसंख्या: None

Review
Folic acid and diseases - supplement it or not?
Dose: None बनाम: Placebo प्रभाव: None None
Review
Prevention of strokes.
Dose: Antiplatelet, antihypertensives, statins बनाम: None Outcome: Stroke prevention प्रभाव: None None

जनसंख्या: Stroke-risk population

Key Statistics

10

अध्ययन

40000

प्रतिभागी

Mixed

C

ग्रेड

Referenced Papers

Revista da Associacao … 2016 62 उद्धरण
Current atherosclerosis reports 2001 2 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
400 mcg DFE/day
homocysteinereduction:
400-800 mcg/day folic acid (with B12 and B6)

अधिकतम सीमा: 1,000 mcg/day folic acid from supplements

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
None -- Positive 800
None -- Neutral 129
None -- Mixed --
Antiplatelet, antihypertensives, statins -- Positive --

सेवन का सर्वोत्तम समय: With or without food; consistent daily timing preferred

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Generally very well-tolerated
  • May mask vitamin B12 deficiency at high doses
  • Rare: mild gastrointestinal discomfort

ज्ञात अंतःक्रियाएँ

  • Methotrexate (folate may reduce efficacy)
  • Antiepileptic drugs (phenytoin, carbamazepine — mutual interference)
  • Vitamin B12 (co-supplementation recommended for homocysteine reduction)

सहनीय अधिकतम सेवन: 1,000 mcg/day folic acid from supplements

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Folate (Vitamin B9) help with Coronary Artery Disease (CAD)?
Based on 10 studies with 40,000 participants, there is limited but promising evidence that Folate (Vitamin B9) may support Coronary Artery Disease (CAD) management. Our evidence grade is C (Some Evidence).
How much Folate (Vitamin B9) should I take for Coronary Artery Disease (CAD)?
Studies have used various dosages. A commonly studied range is 400 mcg DFE/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Folate (Vitamin B9)?
Reported side effects may include Generally very well-tolerated, May mask vitamin B12 deficiency at high doses, Rare: mild gastrointestinal discomfort. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Folate (Vitamin B9) and Coronary Artery Disease (CAD)?
We rate the evidence as Grade C (Some Evidence). This rating is based on 10 peer-reviewed studies with 40,000 total participants. The overall direction of effect is mixed.

इसके लिए अन्य सामग्री Coronary Artery Disease (CAD)

Folate (Vitamin B9) अन्य स्वास्थ्य स्थितियों के लिए

References

  1. [1] Saadet Koc Okudur et al.. J Am Med Dir Assoc. 2021. Excessive Daytime Sleepiness is Associated With Malnutrition, Dysphagia, and Vitamin D Deficiency in Older Adults. doi:10.1016/j.jamda.2021.05.035 PubMed
  2. [2] Safi U Khan et al.. Ann Intern Med. 2019. Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes: An Umbrella Review and Evidence Map. doi:10.7326/M19-0341 PubMed
  3. [3] Siaw-Cheok Liew. Rev Assoc Med Bras (1992). 2016. Folic acid and diseases - supplement it or not? doi:10.1590/1806-9282.62.01.90 PubMed
  4. [4] T J Jeerakathil et al.. Curr Atheroscler Rep. 2001. Prevention of strokes. doi:10.1007/s11883-001-0026-7 PubMed

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।